|
KMID : 0387420090200030169
|
|
Korean Society of Oriental Neuropsychiatry
2009 Volume.20 No. 3 p.169 ~ p.188
|
|
|
Interim Report about The Effect of Bunsimgi-eum(Fenxinqiyin) on the Chest Discomfort of Hwa-byung’s Major Symptom
|
|
Lim Hyeon-Joo
Kim Seok-Hwan
Lee Sang-Ryong
Kang Wee-Chang
Jung In-Chul
|
|
|
Abstract
|
|
|
Objectives: The purpose of this research is to examine the effect of Bunsimgi-eum on the chest discomfort of Hwa-byung’s major symptom.
Methods: In this randomized, double blinded, placebo-controlled study, we planned to give Bunsimgi-eum or controlled medication for major symptoms of Hwa-byung. As preparatory research, 100 mm Visual Analogue Scale(VAS) for chest discomfort, the Hwa-byung’ major symptom was measured as the 1st evaluative instrument, and Likert scale for major symptom of Hwa-byung, Korean State-Trait Anger Expression Inventory(STAXI-K), Korean State-Trait Anxiety Inventory (STAI-K), Korean Beck’s Depression Inventory(BDI-K) and Heart Rate Variability(HRV) were also measured as the 2nd evaluative instrument at the before treatment.
Results: Clinical characteristics-vital signs & demographic characteristics showed no significant difference between both groups. The characteristics of disease-chief complaint, pattern Identification, period, etiological factor, etc, also showed no significant difference between both groups. There were almost no Coincidence between pattern identification & weight of Hwa-byung’s major symptoms. The results of Chest PA, EKG and clinicopathologic examination showed no significant difference between both groups. There were no significant difference between both groups in all valuation scales; 100 mm Visual Analogue Scale for chest discomfort, the Hwa-byung’ major symptom was measured as the 1st evaluative instrument, and Likert scale for major symptom of Hwa-byung, STAXI-K, STAI-K, BDI-K and HRV.
Conclusions: We considered that establishment of experimental group and controlled group was objective and worth conducting this research. And this methodology is expected to be applied to the subsequent research. And also, we hope to make up for this study through various study and discussion.
|
|
|
KEYWORD
|
|
|
Hwa-byung, Bunsimgi-eum(Fenxinqiyin), Clinical Trial, Randomized, Double Blinded, Placebo-controlled Study
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|